SEARCH RESULTS FOR:
Olufemi Abegunde
PARTNER AND LEADER OF THE ENERGY AND RESOURCES INDUSTRY, DELOITTE NIGERIA
"I believe the government is doing its best to put incentives in place. However, the delay in pinning down some of the key fiscal terms for oil industry operators in Nigeria, which is largely due to political factors, is hurting the system."
Miguel Benedetto
DIRECTOR GENERAL, ANIQ
ANIQ describe the impact of the Coronavirus on Mexico’s chemical industry and outlines the challenges of the year ahead.
Roel Schaapveld
CEO, INTERNA TECHNOLOGIES
United States Biopharmaceuticals 2020
InteRNA is a Dutch biotechnology company specializing in the development of RNA therapeutics for the treatment of cancer.
Juan Castaño
CEO, AMPHOS 21 CHILE
Chile Mining 2020 EXPOMIN Official Investment Guide
Amphos 21 helps Chile’s miners to cope with the dearth of water in a sustainable and efficient manner.
Ravi Udaya Bhaskar
DIRECTOR GENERAL, PHARMEXCIL
India’s Pharmexcil discusses developments in the country’s pharmaceuticals segment.
Chris Taylor
PRESIDENT & CEO, GREAT BEAR RESOURCES
Gold Report 2020/2021
“The LP Fault is one of the largest gold targets in Canada considering strike length and depth potential and it behooves us as a company to show what a discovery of this magnitude can deliver. Drilling is key to put meat on the bones. Exploration highlights are important, but showing continuity and grade over distance is the real target here.”
Tomás Buttazzoni
GENERAL MANAGER, TECHNOSTEEL
Chile Mining 2020 EXPOMIN Official Investment Guide
Technosteel is a Chilean company developing solutions for conveyor belts and equipment for mining exploration.
Anthony Capobianco
FOUNDER AND PRESIDENT, STEMSYNERGY THERAPEUTICS
United States Biopharmaceuticals 2020
StemSynergy Therapeutics (SSTI) is a biotechnology company focused on discovering drugs that target biomolecules and cellular processes fundamental to cancer.
Roberto Santos
CEO, UNIGEL
Unigel explains the impact of COVID-19 on Brazil’s chemical sector and why there is confidence that the industry is recovering.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
